1846P Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer

Authors :: P Y Song
B. Stein
C.A. Connell
Stephen T. Sonis
B. Framroze
Shawgi Sukumaran
A. Lategan
G. Landers
J.A. Wetter
V.J. Bray
P A Kraus
D. Osei-Fofie
M. Dimitriu
Jeffrey A. Gelfand
H. Mun
Source :: Annals of Oncology. 31:S1058-S1059
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Head neck
Cancer
Hematology
medicine.disease
Pharmacokinetics
Internal medicine
medicine
Dose escalation
Mucositis
In patient
business

Tools